1. Home
  2. NICE Guidance
  3. Health and social care delivery
  4. Medicines management
  5. Medicines management: general and other

Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes

NICE guideline [NG5] Published date: March 2015

Uptake of this guidance

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Surveillance report
  • 2019 surveillance of medicines adherence (NICE guideline CG76) and medicines optimisation (NICE guideline NG5)
  • Appendix A1: Summary of evidence from surveillance (medicines adherence) 27 March 2019   PDF 1.13 MB
  • Appendix B1: Stakeholder consultation comments table (medicines adherence) 27 March 2019   PDF 782.22 KB
  • Appendix A2: Summary of evidence from surveillance (medicines optimisation) 27 March 2019   PDF 881.19 KB
  • Appendix B2: Stakeholder consultation comments table (medicines optimisation) 27 March 2019   PDF 659.55 KB
  • Full guidance
  • Appendices 04 March 2015   PDF 8.41 MB
  • Full guideline 04 March 2015   PDF 3.87 MB
NICE
  • About NICE
  • Into practice
  • News
  • Contact us
  • Leave feedback
  • Jobs
  • Newsletters and alerts
  • Blog
  • Twitter
  • YouTube
  •   Facebook
  • LinkedIn

Explore

  • Guidance
  • Pathways
  • Standards and indicators
  • Evidence search
  • BNF
  • BNFC
  • Clinical knowledge summaries
  • Journals and databases

Reusing our content

  • Reuse information
  • NICE UK Open Content Licence

Get involved

  • Register as a stakeholder
  • Citizens council
  • Consultations
  • Fellows and scholars
  • Join a committee
  • Meetings in public
  • Student champions
  • Tenders
  • NICE and the public
  • Accessibility
  • Freedom of information
  • Syndication services
  • Glossary
  • Terms and conditions
  • Privacy notice

© NICE [year]. All rights reserved. Subject to Notice of rights.